Cargando…
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer
Biomarkers can be used for diagnosis, prognosis, and prediction in targeted therapy. The estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) are standard biomarkers used in breast cancer for guiding disease treatment. The androgen receptor (AR), a nuclear hormone receptor,...
Autores principales: | You, Chan-Ping, Leung, Man-Hong, Tsang, Wai-Chung, Khoo, Ui-Soon, Tsoi, Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774219/ https://www.ncbi.nlm.nih.gov/pubmed/35053220 http://dx.doi.org/10.3390/biom12010072 |
Ejemplares similares
-
Modulating the Activity of Androgen Receptor for Treating Breast Cancer
por: You, Chan-Ping, et al.
Publicado: (2022) -
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022) -
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022) -
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2021) -
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2023)